• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Frederick G. Barker, MD


  • Jones PS, Aghi MK, Muzikansky A, Shih HA, Barker FG, Curry WT.Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.J Clin Neurosci. 2014 May 19.
  • Jones PS, Aghi MK, Muzikansky A, Shih HA, Barker FG, Curry WT.Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database.J Clin Neurosci. 2014 Apr 29.
  • Herr MW, Sethi RK, Meier JC, Chambers KJ, Remenschneider A, Chan A, Curry WT, Barker FG, Deschler DG, Lin DT.Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy.J Neurol Surg B Skull Base. 2014 Feb;75(1):58-64.
  • Plotkin SR, Merker VL, Muzikansky A, Barker FG, Slattery W.Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients.Otol. Neurotol. 2014 Jan;35(1):e50-6.
  • Plotkin SR, Ardern-Holmes SL, Barker FG, Blakeley JO, Evans DG, Ferner RE, Hadlock TA, Halpin C, .Hearing and facial function outcomes for neurofibromatosis 2 clinical trials.Neurology. 2013 Nov 19;81(21 Suppl 1):S25-32.
  • McDuff SG, Taich ZJ, Lawson JD, Sanghvi P, Wong ET, Barker FG, Hochberg FH, Loeffler JS, Warnke PC, Murphy KT, Mundt AJ, Carter BS, McDonald CR, Chen CC.Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases.J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1384-91.
  • Terry AR, Barker FG, Leffert L, Bateman BT, Souter I, Plotkin SR.Neurofibromatosis type 1 and pregnancy complications: a┬ápopulation-based study.Am J Obstet Gynecol. 2013 Mar 25.
  • Nunes FP, Merker VL, Jennings D, Caruso PA, di Tomaso E, Muzikansky A, Barker FG, Stemmer-Rachamimov A, Plotkin SR.Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients.PLoS ONE. 2013;8(3):e59941.
  • Dilwali S, Lysaght A, Roberts D, Barker FG, McKenna MJ, Stankovic KM.Sporadic Vestibular Schwannomas Associated With Good Hearing Secrete Higher Levels of Fibroblast Growth Factor 2 Than Those Associated With Poor Hearing Irrespective of Tumor Size.Otol. Neurotol. 2013 Mar 18.
  • Jones PS, Dunn GP, Barker FG, Curry WT, Hochberg FH, Cahill DP.Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th Annual Frye-Halloran Brain Tumor Symposium.Neurosurg Focus. 2013 Feb;34(2):E9.
  • Yanamadala V, Walcott BP, Nahed BV, Barker FG.Retrograde Third Ventriculocisternostomy from the Posterior Fossa.Neurosurgery. 2012 Oct 3.
  • Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG.Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.Otol. Neurotol. 2012 Aug;33(6):1046-52.
  • Terry AR, Barker FG, Leffert L, Bateman BT, Souter I, Plotkin SR.Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study.Neuro Oncology. 2012 Jun;14(6):768-76.
  • Plotkin SR, Halpin C, McKenna MJ, Loeffler JS, Batchelor TT, Barker FG.Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.Otol. Neurotol. 2010 Sep;31(7):1135-43.
  • Cahill DP, Barker FG, Davis KR, Kalva SP, Sahai I, Frosch MP.Case records of the Massachusetts General Hospital. Case 10-2010. A 37-year-old woman with weakness and a mass in the brain.N Engl J Med. 2010 Apr 8;362(14):1326-33.
  • Curry WT, Carter BS, Barker FG.Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004.Neurosurgery. 2010 Mar;66(3):427-37; discussion 437-8.
  • Gabeau-Lacet D, Engler D, Gupta S, Scangas GA, Betensky RA, Barker FG, Loeffler JS, Louis DN, Mohapatra G.Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.J Neuropathol Exp Neurol. 2009 Oct;68(10):1155-65.
  • Truong MT, Kamat UR, Liebsch NJ, Curry WT, Lin DT, Barker FG, Loeffler JS, Chan AW.Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors.Head Neck. 2009 Oct;31(10):1297-308.
  • Plotkin SR, Stemmer-Rachamimov AO, Barker FG, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E.Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.N Engl J Med. 2009 Jul 23;361(4):358-67.
  • Aghi MK,Batchelor TT,Louis DN,Barker FG 2nd,Curry WT Jr.Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q.J Neurooncol. 2009 May;93(1):115-20.
  • Plotkin SR,Halpin C,Blakeley JO,Slattery WH 3rd,Welling DB,Chang SM,Loeffler JS,Harris GJ,Sorensen AG,McKenna MJ,Barker FG 2nd.Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.J Neurooncol. 2009 May;93(1):61-77. Review.
  • Curry WT Jr,Barker FG 2nd.Racial, ethnic and socioeconomic disparities in the treatment of brain tumors.J Neurooncol. 2009 May;93(1):25-39. Review.
  • Vogelbaum MA, Asher AL, Kondziolka D, Boulis NM, Selden NR, Hoh BL, Barker FG.Modern treatment of cerebral metastases: Integrated Medical Learning(SM) at CNS 2007.J. Neurooncol. 2009 May;93(1):89-105.
  • Aghi MK,Carter BS,Cosgrove GR,Ojemann RG,Amin-Hanjani S,Martuza RL,Curry WT Jr,Barker FG 2nd.Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.Neurosurgery. 2009 Jan;64(1):56-60; discussion 60.
  • Sher DJ, Henson JW, Avutu B, Hochberg FH, Batchelor TT, Martuza RL, Barker FG 2nd, Loeffler JS, Chakravarti A.The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.J Neurooncol. 2008 May;88(1):43-50.
  • Aqel N, Barker F, Patel K, Naresh KN.In-situ mantle cell lymphoma--a report of two cases.Histopathology. 2008 Jan;52(2):256-60.
  • Aghi MK, Eskandar EN, Carter BS, Curry WT Jr, Barker FG 2nd.Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas.Neurosurgery. 2007 Oct;61(4):754-60; discussion 760-1.
  • Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, Barker FG 2nd, Buckner JC, James CD, Aldape K.Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.J Clin Oncol. 2007 Jun 1;25(16):2288-94.
  • Barnholtz-Sloan JS, Maldonado JL, Williams VL, Curry WT, Rodkey EA, Barker FG 2nd, Sloan AE.Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.J Neurooncol. 2007 Nov;85(2):171-80.
  • Barker FG.Efficacy of prophylactic antibiotics against meningitis after craniotomy: a meta-analysis.Neurosurgery. 2007 May;60(5):887-94; discussion 887-94.
  • Ghogawala Z, Coumans JV, Benzel EC, Stabile LM, Barker FG.Ventral versus dorsal decompression for cervical spondylotic myelopathy: surgeons' assessment of eligibility for randomization in a proposed randomized controlled trial: results of a survey of the Cervical Spine Research Society.Spine. 2007 Feb 15;32(4):429-36.
  • Pommier P, Liebsch NJ, Deschler DG, Lin DT, McIntyre JF, Barker FG, Adams JA, Lopes VV, Varvares M, Loeffler JS, Chan AW.Proton beam radiation therapy for skull base adenoid cystic carcinoma.Arch Otolaryngol Head Neck Surg. 2006 Nov;132(11):1242-9.
  • Ulmer S, Braga TA, Barker FG, Lev MH, Gonzalez RG, Henson JW.Clinical and radiographic features of peritumoral infarction following resection of glioblastoma.Neurology. 2006 Nov 14;67(9):1668-70.
  • Smith ER, Butler WE, Barker FG.Is there a "July phenomenon" in pediatric neurosurgery at teaching hospitals?.J Neurosurg. 2006 Sep;105(3 Suppl):169-76.
  • Barker FG.Brain metastasis.J Neurosurg. 2006 Sep;105(3):371-2; discussion 372-4.
  • Eskandar E, Barker FG, Rabinov JD.Case records of the Massachusetts General Hospital. Case 21-2006. A 61-year-old man with left-sided facial pain.N Engl J Med. 2006 Jul 13;355(2):183-8.
  • Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, Fuller GN, Aldape KD.Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.Clin Cancer Res. 2006 Jul 1;12(13):3935-41.
  • Flickinger JC, Barker FG.Clinical results: radiosurgery and radiotherapy of cranial nerve schwannomas.Neurosurg Clin N Am. 2006 Apr;17(2):121-8. Review.
  • Barker FG, Chang SM.Improving resection of malignant glioma.Lancet Oncol. 2006 May;7(5):359-60.
  • Aghi M, Kluwe L, Webster MT, Jacoby LB, Barker FG, Ojemann RG, Mautner VF, MacCollin M.Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.J Neurosurg. 2006 Feb;104(2):201-7.
  • Aghi M, Gaviani P, Henson JW, Batchelor TT, Louis DN, Barker FG.Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8600-5.
  • Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS, Barker FG.Extracranial-intracranial bypass in the treatment of occlusive cerebrovascular disease and intracranial aneurysms in the United States between 1992 and 2001: a population-based study.J Neurosurg. 2005 Nov;103(5):794-804.
  • Barker FG, Carter BS.Synthesizing medical evidence: systematic reviews and metaanalyses.Neurosurg Focus. 2005 Oct 15;19(4):E5.
  • Mavrakis AN, Halpern EF, Barker FG, Gonzalez RG, Henson JW.Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer.Neurology. 2005 Sep 27;65(6):908-11.
  • Rabinov JD, Barker FG, McKenna MJ, Curtin HD.Virtual cisternoscopy: 3D MRI models of the cerebellopontine angle for lesions related to the cranial nerves.Skull Base. 2004 May;14(2):93-9; discussion 99.
  • Chang SM, Barker FG.Marital status, treatment, and survival in patients with glioblastoma multiforme.Cancer. 2005 Nov 1;104(9):1975-84.
  • Curry WT, McDermott MW, Carter BS, Barker FG.Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload.J Neurosurg. 2005 Jun;102(6):977-86.
  • Curry WT, Butler WE, Barker FG.Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002.Neurosurgery. 2005 Jul;57(1):97-108; discussion 97-108.
  • Chan AW, Black P, Ojemann RG, Barker FG, Kooy HM, Lopes VV, McKenna MJ, Shrieve DC, Martuza RL, Loeffler JS.Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity.Neurosurgery. 2005 Jul;57(1):60-70; discussion 60-70.
  • Barker FG, McDermott MW.Prizes, lectures, and awards of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors.Neurosurg Focus. 2005 Apr 15;18(4):e11.
  • Barker FG.Surgical and radiosurgical management of brain metastases.Surg Clin North Am. 2005 Apr;85(2):329-45.
  • Barker FG, Curry WT, Carter BS.Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.Neuro-oncol. 2005 Jan;7(1):49-63.
  • Barker FG, Linskey ME.History of the AANS/CNS joint section on tumors and preface to the 20th anniversary Journal of Neuro-Oncology Special Issue.J Neurooncol. 2004 Aug-Sep;69(1-3):1-18.
  • Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, Kracher J, Grossman SA, Fisher JD, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, Nabors LB, Brem S, Phuphanich S, Freeman S, Kaplan R, Zwiebel J.A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.Mol Ther. 2004 Nov;10(5):958-66.
  • Ghogawala Z, Benzel EC, Amin-Hanjani S, Barker FG, Harrington JF, Magge SN, Strugar J, Coumans JV, Borges LF.Prospective outcomes evaluation after decompression with or without instrumented fusion for lumbar stenosis and degenerative Grade I spondylolisthesis.J Neurosurg Spine. 2004 Oct;1(3):267-72.
  • Barker FG, Amin-Hanjani S.Changing neurosurgical workload in the United States, 1988-2001: craniotomy other than trauma in adults.Neurosurgery. 2004 Sep;55(3):506-17; discussion 517-8.
  • Smith ER, Butler WE, Barker FG.Craniotomy for resection of pediatric brain tumors in the United States, 1988 to 2000: effects of provider caseloads and progressive centralization and specialization of care.Neurosurgery. 2004 Mar;54(3):553-63; discussion 563-5.
  • Barker FG.Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload.Cancer. 2004 Mar 1;100(5):999-1007.
  • Smith ER, Butler WE, Barker FG.In-hospital mortality rates after ventriculoperitoneal shunt procedures in the United States, 1998 to 2000: relation to hospital and surgeon volume of care.J Neurosurg Spine. 2004 Feb;100(2):90-7.
  • Amin-Hanjani S, Ogilvy CS, Barker FG.Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis.Neurosurgery. 2004 Feb;54(2):326-34; discussion 334-5.
  • Ramsey MJ, McKenna MJ, Barker FG.Superior semicircular canal dehiscence syndrome. Case report.J Neurosurg. 2004 Jan;100(1):123-4.
  • Barker FG, Amin-Hanjani S, Butler WE, Hoh BL, Rabinov JD, Pryor JC, Ogilvy CS, Carter BS.Age-dependent differences in short-term outcome after surgical or endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000.Neurosurgery. 2004 Jan;54(1):18-28; discussion 28-30.
  • Eskandar EN, Flaherty A, Cosgrove GR, Shinobu LA, Barker FG.Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample.J Neurosurg. 2003 Nov;99(5):863-71.
  • Barker FG, Klibanski A, Swearingen B.Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.J Clin Endocrinol Metab. 2003 Oct;88(10):4709-19.
  • Weber DC, Chan AW, Bussiere MR, Harsh GR, Ancukiewicz M, Barker FG, Thornton AT, Martuza RL, Nadol JB, Chapman PH, Loeffler JS.Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity.Neurosurgery. 2003 Sep;53(3):577-86; discussion 586-8.
  • Barker FG, Butler WE, Lyons S, Cascio E, Ogilvy CS, Loeffler JS, Chapman PH.Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations.J Neurosurg. 2003 Aug;99(2):254-63.
  • Hoh BL, Rabinov JD, Pryor JC, Carter BS, Barker FG.In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume.AJNR Am J Neuroradiol. 2003 Aug;24(7):1409-20.
  • Barker FG, Carter BS, Ojemann RG, Jyung RW, Poe DS, McKenna MJ.Surgical excision of acoustic neuroma: patient outcome and provider caseload.Laryngoscope. 2003 Aug;113(8):1332-43.
  • Chang SM, Parney IF, McDermott M, Barker FG, Schmidt MH, Huang W, Laws ER, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M,.Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project.J Neurosurg. 2003 Jun;98(6):1175-81.
  • Kalkanis SN, Eskandar EN, Carter BS, Barker FG.Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes.Neurosurgery. 2003 Jun;52(6):1251-61; discussion 1261-.
  • Barker FG, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS.In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume.Neurosurgery. 2003 May;52(5):995-1007; discussion 1007.
  • Rabinov JD, Lee PL, Barker FG, Louis DN, Harsh GR, Cosgrove GR, Chiocca EA, Thornton AF, Loeffler JS, Henson JW, Gonzalez RG.In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience.Radiology. 2002 Dec;225(3):871-9.
  • Barker FG.Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis.Neurosurgery. 2002 Aug;51(2):391-400; discussion 400-1.
  • Chang SM, Barker FG, Schmidt MH, Sloan AE, Kasper R, Phillips L, Shih K, Hariharan S, Berger MS.Clinical trial participation among patients enrolled in the Glioma Outcomes Project.Cancer. 2002 May 15;94(10):2681-7.
  • Barker FG, Chang SM, Larson DA, Sneed PK, Wara WM, Wilson CB, Prados MD.Age and radiation response in glioblastoma multiforme.Neurosurgery. 2001 Dec;49(6):1288-97; discussion 1297-.
  • Barker FG, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, Wara WM, Berger MS, Chen P, Israel MA, Aldape KD.EGFR overexpression and radiation response in glioblastoma multiforme.Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):410-8.
  • Barker FG, Amin-Hanjani S, Butler WE, Lyons S, Ojemann RG, Chapman PH, Ogilvy CS.Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system.Neurosurgery. 2001 Jul;49(1):15-24; discussion 24-5.
  • Simmons ML, Lamborn KR, Takahashi M, Chen P, Israel MA, Berger MS, Godfrey T, Nigro J, Prados M, Chang S, Barker FG, Aldape K.Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.Cancer Res. 2001 Feb 1;61(3):1122-8.
  • Swearingen B, Barker FG, Zervas NT.The management of pituitary adenomas: the MGH experience.Clin Neurosurg. 1999;45:48-56.
  • Wackym PA, King WA, Poe DS, Meyer GA, Ojemann RG, Barker FG, Walsh PR, Staecker H.Adjunctive use of endoscopy during acoustic neuroma surgery.Laryngoscope. 1999 Aug;109(8):1193-201.
  • Swearingen B, Biller BM, Barker FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT.Long-term mortality after transsphenoidal surgery for Cushing disease.Ann Intern Med. 1999 May 18;130(10):821-4.
  • Loeffler JS, Barker FG, Chapman PH.Role of radiosurgery in the management of central nervous system metastases.Cancer Chemother Pharmacol. 1999;43 Suppl:S11-4.
  • Wackym PA, King WA, Barker FG, Poe DS.Endoscope-assisted vestibular neurectomy.Laryngoscope. 1998 Dec;108(12):1787-93.
  • Swearingen B, Barker FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT.Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.J Clin Endocrinol Metab. 1998 Oct;83(10):3419-26.
  • Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB.Survival and functional status after resection of recurrent glioblastoma multiforme.Neurosurgery. 1998 Apr;42(4):709-20; discussion 720-3.
  • Chang SM, Barker FG, Huhn SL, Nicholas MK, Page M, Rabbitt J, Prados MD.High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma.J Neurooncol. 1998 Apr;37(2):169-76.
  • Barker FG, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD.Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors.Cancer. 1997 Sep 1;80(5):936-41.
  • Barker FG.Repairing holes in the head: a history of cranioplasty.Neurosurgery. 1997 Oct;41(4):999.
  • Barker FG, Chen P, Furman F, Aldape KD, Edwards MS, Israel MA.P16 deletion and mutation analysis in human brain tumors.J Neurooncol. 1997 Jan;31(1-2):17-23.
  • Barker FG, Chang SM, Valk PE, Pounds TR, Prados MD.18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.Cancer. 1997 Jan 1;79(1):115-26.
  • Barker FG, Jannetta PJ, Bissonette DJ, Jho HD.Trigeminal numbness and tic relief after microvascular decompression for typical trigeminal neuralgia.Neurosurgery. 1997 Jan;40(1):39-45.
  • Ogilvy CS, Barker FG, Joseph MP, Cheney ML, Swearingen B, Crowell RM.Transfacial transclival approach for midline posterior circulation aneurysms.Neurosurgery. 1996 Oct;39(4):736-41; discussion 742.
  • Barker FG.Analysis of the relationship between long-term operative success and a transient or delayed operative side effect.Neurosurgery. 1996 Aug;39(2):412-5; discussion 415-6.
  • Barker FG, Jannetta PJ, Babu RP, Pomonis S, Bissonette DJ, Jho HD.Long-term outcome after operation for trigeminal neuralgia in patients with posterior fossa tumors.J Neurosurg. 1996 May;84(5):818-25.
  • Barker FG, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD.The long-term outcome of microvascular decompression for trigeminal neuralgia.N Engl J Med. 1996 Apr 25;334(17):1077-83.
  • Barker FG, Davis RL, Chang SM, Prados MD.Necrosis as a prognostic factor in glioblastoma multiforme.Cancer. 1996 Mar 15;77(6):1161-6.
  • Barker FG, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK, McDermott MW, Sneed PK, Wara WM, Wilson CB.Radiation response and survival time in patients with glioblastoma multiforme.J Neurosurg. 1996 Mar;84(3):442-8.
  • Barker FG, Prados MD, Chang SM, Davis RL, Gutin PH, Lamborn KR, Larson DA, McDermott MW, Sneed PK, Wilson CB.Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.Int J Radiat Oncol Biol Phys. 1996 Mar 1;34(4):803-8.
  • Barker FG, Ogilvy CS.Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis.J Neurosurg. 1996 Mar;84(3):405-14.
  • Butler WE, Barker FG, Crowell RM.Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis.Neurosurgery. 1996 Mar;38(3):506-15; discussion 515-6.
  • Fick J, Barker FG, Dazin P, Westphale EM, Beyer EC, Israel MA.The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro.Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11071-5.
  • Barker FG, Israel MA.The molecular biology of brain tumors.Neurol Clin. 1995 Nov;13(4):701-21.
  • Chang SM, Barker FG, Larson DA, Bollen AW, Prados MD.Sarcomas subsequent to cranial irradiation.Neurosurgery. 1995 Apr;36(4):685-90.
  • Barker FG.Phineas among the phrenologists: the American crowbar case and nineteenth-century theories of cerebral localization.J Neurosurg. 1995 Apr;82(4):672-82.
  • Barker FG, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD.Microvascular decompression for hemifacial spasm.J Neurosurg. 1995 Feb;82(2):201-10.
  • Barker FG, Ogilvy CS, Chin JK, Joseph MP, Pile-Spellman J, Crowell RM.Transethmoidal transsphenoidal approach for embolization of a carotid-cavernous fistula. Case report.J Neurosurg. 1994 Dec;81(6):921-3.
  • Barker FG.Efficacy of prophylactic antibiotics for craniotomy: a meta-analysis.Neurosurgery. 1994 Sep;35(3):484-90; discussion 491-2.
  • Barker FG, Tatter SB.Flow-directed atrial catheter placement for ventriculoatrial shunts: technical note.Neurosurgery. 1994 Sep;35(3):534-5; discussion 535-6.
  • Barker FG.The Massachusetts General Hospital. Early history and neurosurgery to 1939.J Neurosurg. 1993 Dec;79(6):948-59.
  • Frim DM, Barker FG, Poletti CE, Hamilton AJ.Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients.Neurosurgery. 1992 Jun;30(6):830-2; discussion 832-3.
  • Barker FG, Heros RC.Clinical aspects of vasospasm.Neurosurg Clin N Am. 1990 Apr;1(2):277-88.